Medications for Positron Emission Tomography Imaging
Other names: PET Imaging
Drugs used to treat Positron Emission Tomography Imaging
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
rubidium chloride rb-82 | Rate | Add review | Rx | ||||
Generic name: rubidium chloride rb-82 systemic Brand names: Cardiogen-82, Ruby-Fill Drug class: diagnostic radiopharmaceuticals For consumers: side effects |
|||||||
Neuraceq | Rate | Add review | Rx | ||||
Generic name: florbetaben f-18 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
Vizamyl | Rate | Add review | Rx | ||||
Generic name: flutemetamol f-18 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
florbetapir F 18 | Rate | Add review | Rx | ||||
Generic name: florbetapir F 18 systemic Brand name: Amyvid Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects |
|||||||
Amyvid | Rate | Add review | Rx | ||||
Generic name: florbetapir F 18 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
Axumin | Rate | Add review | Rx | ||||
Generic name: fluciclovine F 18 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
Cardiogen-82 | Rate | Add review | Rx | ||||
Generic name: rubidium chloride rb-82 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
gallium ga 68 dotatate | Rate | Add review | Rx | ||||
Generic name: gallium ga 68 dotatate systemic Brand name: Netspot Drug class: radiologic conjugating agents For consumers: dosage, interactions, side effects |
|||||||
fluciclovine F 18 | Rate | Add review | Rx | ||||
Generic name: fluciclovine F 18 systemic Brand name: Axumin Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects |
|||||||
Cerianna | Rate | Add review | Rx | ||||
Generic name: fluoroestradiol F 18 systemic For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
choline c-11 | Rate | Add review | Rx | ||||
Generic name: choline c-11 systemic For consumers: For professionals: Prescribing Information |
|||||||
flutemetamol f-18 | Rate | Add review | Rx | ||||
Generic name: flutemetamol f-18 systemic Brand name: Vizamyl Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects |
|||||||
florbetaben f-18 | Rate | Add review | Rx | ||||
Generic name: florbetaben f-18 systemic Brand name: Neuraceq Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects |
|||||||
Ruby-Fill | Rate | Add review | Rx | ||||
Generic name: rubidium chloride rb-82 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, side effects For professionals: Prescribing Information |
|||||||
fluoroestradiol F 18 | Rate | Add review | Rx | ||||
Generic name: fluoroestradiol F 18 systemic Brand name: Cerianna For consumers: side effects |
|||||||
gallium ga 68 psma-11 | Rate | Add review | Rx | ||||
Generic name: gallium ga 68 psma-11 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Netspot | Rate | Add review | Rx | ||||
Generic name: gallium ga 68 dotatate systemic Drug class: radiologic conjugating agents For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Tauvid | Rate | Add review | Rx | ||||
Generic name: flortaucipir F 18 systemic For consumers: dosage, For professionals: Prescribing Information |
|||||||
gallium ga-68 dotatoc | Rate | Add review | Rx | ||||
Generic name: gallium ga-68 dotatoc systemic For consumers: |
|||||||
piflufolastat F 18 | Rate | Add review | Rx | ||||
Generic name: piflufolastat F 18 systemic Brand name: Pylarify Drug class: diagnostic radiopharmaceuticals For consumers: dosage, interactions, side effects |
|||||||
Pylarify | Rate | Add review | Rx | ||||
Generic name: piflufolastat F 18 systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Detectnet | Rate | Add review | Rx | ||||
Generic name: copper Cu 64 dotatate systemic Drug class: diagnostic radiopharmaceuticals For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
copper Cu 64 dotatate | Rate | Add review | Rx | ||||
Generic name: copper Cu 64 dotatate systemic Brand name: Detectnet Drug class: diagnostic radiopharmaceuticals For consumers: interactions, side effects |
|||||||
flortaucipir F 18 | Rate | Add review | Rx | ||||
Generic name: flortaucipir F 18 systemic Brand name: Tauvid For consumers: |
|||||||
Illuccix | Rate | Add review | Rx | ||||
Generic name: gallium Ga 68 gozetotide systemic Drug class: radiologic conjugating agents For consumers: dosage, interactions, For professionals: Prescribing Information |
|||||||
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.